Amyloid-associated proteins α1-antichymotrypsin and apolipoprotein E promote assembly of Alzheimer β-protein into filaments

Gene Dose of Apolipoprotein E Type 4 Allele and the Risk of Alzheimer's Disease in Late Onset Families

Corder, E. H., Saunders, A. M., Strittmatter, W. J., Schmechel, D. E., Gaskell, P. C., Small, G. W., Roses, A. D., Haines, J. L., & Pericak-Vance, M. A. (1993) · Science · doi:10.1126/science.8346443 · Cited by 9,429

Apolipoprotein E: high-avidity binding to beta-amyloid and increased frequency of type 4 allele in late-onset familial Alzheimer disease.

Strittmatter, W. J., Saunders, A. M., Schmechel, D., Pericak-Vance, M., Enghild, J., Salvesen, G. S., & Roses, A. D. (1993) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.90.5.1977 · Cited by 4,268

Amyloid β-peptide is produced by cultured cells during normal metabolism

Haass, C., Schlossmacher, M. G., Hung, A. Y., Vigo-Pelfrey, C., Mellon, A., Ostaszewski, B. L., Lieberburg, I., Koo, E. H., Schenk, D., Teplow, D. B., et al. (1992) · Nature · doi:10.1038/359322a0 · Cited by 1,921

Protective effect of apolipoprotein E type 2 allele for late onset Alzheimer disease

Corder, E. H., Saunders, A. M., Risch, N. J., Strittmatter, W. J., Schmechel, D. E., Gaskell, P. C., Rimmler, J. B., Locke, P. A., Conneally, P. M., Schmader, K. E., et al. (1994) · Nature Genetics · doi:10.1038/ng0694-180 · Cited by 1,920

Visualization of Aβ42(43) and Aβ40 in senile plaques with end-specific Aβ monoclonals: Evidence that an initially deposited species is Aβ42(43)

Iwatsubo, T., Odaka, A., Suzuki, N., Mizusawa, H., Nukina, N., & Ihara, Y. (1994) · Neuron · doi:10.1016/0896-6273(94)90458-8 · Cited by 1,774

Isolation and quantification of soluble Alzheimer's β-peptide from biological fluids

Seubert, P., Vigo-Pelfrey, C., Esch, F., Lee, M., Dovey, H., Davis, D., Sinha, S., Schiossmacher, M., Whaley, J., Swindlehurst, C., et al. (1992) · Nature · doi:10.1038/359325a0 · Cited by 1,731

Increased amyloid beta-peptide deposition in cerebral cortex as a consequence of apolipoprotein E genotype in late-onset Alzheimer disease.

Schmechel, D. E., Saunders, A. M., Strittmatter, W. J., Crain, B. J., Hulette, C. M., Joo, S. H., Pericak-Vance, M. A., Goldgaber, D., & Roses, A. D. (1993) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.90.20.9649 · Cited by 1,525

An Increased Percentage of Long Amyloid β Protein Secreted by Familial Amyloid β Protein Precursor (βApp 717 ) Mutants

Suzuki, N., Cheung, T. T., Cai, X.-D., Odaka, A., Otvos, L., Eckman, C., Golde, T. E., & Younkin, S. G. (1994) · Science · doi:10.1126/science.8191290 · Cited by 1,471

Production of the Alzheimer Amyloid β Protein by Normal Proteolytic Processing

Shoji, M., Golde, T. E., Ghiso, J., Cheung, T. T., Estus, S., Shaffer, L. M., Cai, X.-D., McKay, D. M., Tintner, R., Frangione, B., et al. (1992) · Science · doi:10.1126/science.1439760 · Cited by 1,447

Apolipoprotein E immunoreactivity in cerebral amyloid deposits and neurofibrillary tangles in Alzheimer's disease and kuru plaque amyloid in Creutzfeldt-Jakob disease

Namba, Y., Tomonaga, M., Kawasaki, H., Otomo, E., & Ikeda, K. (1991) · Brain Research · doi:10.1016/0006-8993(91)91092-f · Cited by 1,157

The Amyloid Peptide and Its Precursor in Alzheimer's Disease

Octave, J. N. (1995) · Reviews in the Neurosciences · doi:10.1515/revneuro.1995.6.4.287 · Cited by 34

Alpha-1-antichymotrypsin bi-allele polymorphism, apolipoprotein-E tri-allele polymorphism and genetic risk of Alzheimer's syndrome

Thome, J., Baumer, A., Kornhuber, J., Rösler, M., & Riederer, P. F. (1995) · Journal of Neural Transmission - Parkinsons Disease and Dementia Section · doi:10.1007/bf02251232 · Cited by 34

Potential genetic markers of sporadic Alzheimerʼs dementia

Retz, W., Thome, J., Durany, N., Harsányi, A., Retz-Junginger, P., Kornhuber, J., Riederer, P., & Rösler, M. (2001) · Psychiatric Genetics · doi:10.1097/00041444-200109000-00002 · Cited by 48

Alkaloids as Potential Multi-Target Drugs to Treat Alzheimer's Disease

Lima, J. A., & Hamerski, L. (2018) · Studies in natural products chemistry · doi:10.1016/b978-0-444-64183-0.00008-7 · Cited by 34

Molecular chaperons, amyloid and preamyloid lesions in the BRI2 gene‐related dementias: a morphological study

Lashley, T., Holton, J. L., Verbeek, M. M., Rostagno, A. A., Bojsen‐Møller, M., David, G., van Horssen, J., Brændgaard, H., Plant, G. T., Frangione, B., et al. (2006) · Neuropathology and Applied Neurobiology · doi:10.1111/j.1365-2990.2006.00747.x · Cited by 33

Human apolipoprotein E allele-specific brain expressing transgenic mice

Smith, J. D., Sikes, J. L., & Levin-Allerhand, J. A. (1998) · Neurobiology of Aging · doi:10.1016/s0197-4580(98)00076-1 · Cited by 33

Astrocytes down‐regulate neuronal β‐amyloid precursor protein expression and modify its processing in an apolipoprotein E isoform‐specific manner

Vincent, B., & Smith, J. D. (2001) · European Journal of Neuroscience · doi:10.1046/j.0953-816x.2001.01643.x · Cited by 32

APOE from astrocytes restores Alzheimer’s Aβ-pathology and DAM-like responses in APOE deficient microglia

Preman, P., Moechars, D., Fertan, E., Wolfs, L., Serneels, L., Shah, D., Lamote, J., Poovathingal, S., Snellinx, A., Mancuso, R., et al. (2024) · EMBO Molecular Medicine · doi:10.1038/s44321-024-00162-7 · Cited by 32

Genetic and biochemical markers for Alzheimer's disease: recent developments

Mulder, C., Scheltens, P., Visser, J. J., van Kamp, G. J., & Schutgens, R. B. H. (2000) · Annals of Clinical Biochemistry International Journal of Laboratory Medicine · doi:10.1258/0004563001899898 · Cited by 32

Nucleation of α1-Antichymotrypsin Polymerization

Crowther, D. C., Serpell, L. C., Dafforn, T. R., Gooptu, B., & Lomas, D. A. (2003) · Biochemistry · doi:10.1021/bi0259305 · Cited by 32

Uses of Evolutionary Theory in the Human Genome Project

Templeton, A. R. (1999) · Annual Review of Ecology and Systematics · doi:10.1146/annurev.ecolsys.30.1.23 · Cited by 32

?1-Antichymotrypsin gene polymorphism and risk for Alzheimer's disease

Muramatsu, T., Matsushita, S., Arai, H., Sasaki, H., & Higuchi, S. (1996) · Journal of Neural Transmission · doi:10.1007/bf01271205 · Cited by 32

Neuroimmunodegeneration: do neurons and T cells use common pathways for cell death?

Lynn, W. S., & Wong, P. K. Y. (1995) · The FASEB Journal · doi:10.1096/fasebj.9.12.7672507 · Cited by 31

The biology of Alzheimer's disease

Edelberg, H. K., & Wei, J. Y. (1996) · Mechanisms of Ageing and Development · doi:10.1016/0047-6374(96)01778-2 · Cited by 34

Amyloid A protein amyloidosis induced in apolipoprotein-E-deficient mice.

Hoshii, Y., Kawano, H., Cui, D., Takeda, T., Gondo, T., Takahashi, M., Kogishi, K., Higuchi, K., & Ishihara, T. (1997) · Europe PMC (PubMed Central) · Cited by 31

Apolipoprotein E, angiotensin-converting enzyme and α-1-antichymotrypsin genotypes are not associated with post-stroke dementia

Arpa, A., del Ser, T., Goda, G., Barba, R., & Bornstein, B. (2003) · Journal of the Neurological Sciences · doi:10.1016/s0022-510x(03)00026-1 · Cited by 31

Clinical and Neuropathological Correlates of Apolipoprotein E Genotype in Alzheimer's Disease ‐ Window on Molecular Epidemiologya

Hyman, B. T., Gómez‐Isla, T., WEST, H., Briggs, M. E., Chung, H., Growdon, J. H., & Rebeck, G. W. (1996) · Annals of the New York Academy of Sciences · doi:10.1111/j.1749-6632.1996.tb34414.x · Cited by 32

α1‐Antichymotrypsin Inhibits Aβ Degradation in Vitro and in Vivo

Abraham, C. R., McGraw, W. T., Slot, F., & Yamin, R. (2000) · Annals of the New York Academy of Sciences · doi:10.1111/j.1749-6632.2000.tb06930.x · Cited by 30

Apolipoprotein E forms stable complexes with recombinant Alzheimer's disease β-amyloid precursor protein

Cristina, H. A. A. S., Cazorla, P., de Miguel, C., Valdivieso, F., & Vázquez, J. (1997) · Biochemical Journal · doi:10.1042/bj3250169 · Cited by 33

Alzheimer's disease, inflammation and non-steroidal anti-inflammatory drugs

Ferencĭk, M., Novák, M., Rovensky, J., & Rybár, I. (2001) · Bratislavské lekárske listy/Bratislava medical journal · doi:10.1007/bf03656411 · Cited by 29

The Modulating Effect of Mechanical Changes in Lipid Bilayers Caused by ApoE-Containing Lipoproteins on Aβ Induced Membrane Disruption

Legleiter, J. A., Fryer, J. D., Holtzman, D. M., & Kowalewski, T. (2011) · ACS Chemical Neuroscience · doi:10.1021/cn2000475 · Cited by 28

Apolipoprotein epsilon 4 genotype is associated with less improvement in cognitive function five years after cardiac surgery: a retrospective cohort study

Bartels, K., Li, Y., Li, Y.-W., White, W. D., Laskowitz, D. T., Kertai, M. D., Stafford‐Smith, M., Podgoreanu, M. V., Newman, M. F., & Mathew, J. P. (2015) · Canadian Journal of Anesthesia/Journal canadien d anesthésie · doi:10.1007/s12630-015-0337-8 · Cited by 29

APOE polymorphism and clinical duration determine regional neuropathology in Swedish APP670, 671 mutation carriers: implications for late‐onset Alzheimer's disease

Bogdanović, N., Corder, E. H., Lannfelt, L., & Winblad, B. G. (2002) · Journal of Cellular and Molecular Medicine · doi:10.1111/j.1582-4934.2002.tb00187.x · Cited by 29

The Role of the Amyloid Protein Precursor (APP) in Alzheimer's Disease: Does the Normal Function of APP Explain the Topography of Neurodegeneration?

Small, D. H. (1998) · Neurochemical Research · doi:10.1023/a:1022471729291 · Cited by 30

Evolvability and Neurodegenerative Disease: Antagonistic Pleiotropy Phenomena Derived from Amyloid Aggregates

Hashimoto, M., Ho, G. J., Takamatsu, Y., Shimizu, Y., Sugama, S., Takenouchi, T., Waragai, M., & Masliah, E. (2018) · Journal of Parkinson s Disease · doi:10.3233/jpd-181365 · Cited by 27

Are apolipoprotein E fragments a promising new therapeutic target for Alzheimer’s disease?

Vecchio, F. L., Bisceglia, P., Imbimbo, B. P., Lozupone, M., Latino, R. R., Resta, E., Leone, M., Solfrizzi, V., Greco, A., Daniele, A., et al. (2022) · Therapeutic Advances in Chronic Disease · doi:10.1177/20406223221081605 · Cited by 28

Extracellular Chaperones

Dabbs, R. A., Wyatt, A. R., Yerbury, J. J., Ecroyd, H. W., & Wilson, M. R. (2011) · Topics in current chemistry · doi:10.1007/128_2011_262 · Cited by 28

Microsatellite polymorphism of the α 1 -antichymotrypsin gene locus associated with sporadic Alzheimer's disease

Morgan, K., Morgan, L., CARPENTER, K., Lowe, J. S., Lam, L., Cave, S., Xuereb, J. H., Wischik, C. M., Harrington, C. R., & Kalsheker, N. A. (1996) · Human Genetics · doi:10.1007/s004390050304 · Cited by 28

Effect of cytokines, dexamethazone and the A/T-signal peptide polymorphism on the expression of alpha1-antichymotrypsin in astrocytes: significance for Alzheimer's disease

Nilsson, L. N. G., Das, S., & Potter, H. (2001) · Neurochemistry International · doi:10.1016/s0197-0186(01)00043-2 · Cited by 28

The non-steroidal anti-inflammatory drug tepoxalin inhibits interleukin-6 and alphal-anti-chymotrypsin synthesis in astrocytes by preventing degradation of IκB-alpha

Fiebich, B. L., Hofer, T. J., Lieb, K., Hüell, M., Butcher, R. D., Schumann, G., Schulze‐Osthoff, K., & Bauer, J. (1999) · Neuropharmacology · doi:10.1016/s0028-3908(99)00055-6 · Cited by 28

Measurement of apolipoprotein E and amyloid β clearance rates in the mouse brain using bolus stable isotope labeling

Basak, J. M., Kim, J., Pyatkivskyy, Y., Wildsmith, K. R., Jiang, H., Parsadanian, M., Patterson, B. W., Bateman, R. J., & Holtzman, D. M. (2012) · Molecular Neurodegeneration · doi:10.1186/1750-1326-7-14 · Cited by 27

Potential Novel Approaches to Understand the Pathogenesis and Treat Alzheimer’s Disease

Drummond, E., Goñi, F., Liu, S., Prelli, F., Scholtzova, H., & Wısnıewskı, T. (2018) · Journal of Alzheimer s Disease · doi:10.3233/jad-179909 · Cited by 26

Comparable amyloid β-protein (Aβ) 42(43) and Aβ40 deposition in the aged monkey brain

Kanemaru, K., Iwatsubo, T., & Ihara, Y. (1996) · Neuroscience Letters · doi:10.1016/0304-3940(96)12893-7 · Cited by 27

Anti-inflammatory substances – a new therapeutic option in Alzheimer's disease

Hüll, M. (1999) · Drug Discovery Today · doi:10.1016/s1359-6446(99)01339-2 · Cited by 27

Immunohistochemical characteristics of the constituents of senile plaques and amyloid angiopathy in aged cynomolgus monkeys

Nakamura, S., Kiatipattanasakul, W., Nakayama, H., Ono, F., Sakakibara, I., Yoshikawa, Y., Naoaki, G. O. T. O., & Doi, K. (1996) · Journal of Medical Primatology · doi:10.1111/j.1600-0684.1996.tb00213.x · Cited by 27

Age-related congophilic inclusions in the brains of apolipoprotein E-deficient mice

Robertson, T. A., Dutton, N., Martins, R. N., Roses, A. D., Kakulas, B. A., & Papadimitriou, J. M. (1997) · Neuroscience · doi:10.1016/s0306-4522(97)00284-4 · Cited by 27

The Role of the Innate Immune System in Alzheimer’s Disease and Frontotemporal Lobar Degeneration: An Eye on Microglia

Ridolfi, E., Barone, C., Scarpini, E. A., & Galimberti, D. (2013) · Clinical and Developmental Immunology · doi:10.1155/2013/939786 · Cited by 28

Granulocyte Macrophage Colony Stimulating Factor Treatment is Associated with Improved Cognition in Cancer Patients

Boyd, H., & Booth‐Jones, M. (2012) · Brain Disorders & Therapy · doi:10.4172/bdt.1000101 · Cited by 25

Aβ20–29 peptide blocking apoE/Aβ interaction reduces full-length Aβ42/40 fibril formation and cytotoxicity in vitro

Hao, J., Zhang, W., Zhang, P., Liu, R., Liu, L., Lei, G., Su, C., Miao, J., & Li, Z. (2010) · Neuropeptides · doi:10.1016/j.npep.2010.03.001 · Cited by 26

Establishment of a first-order kinetic model of light chain-associated amyloid fibril extension in vitro

Takahashi, N., Hasegawa, K., Yamaguchi, I., Okada, H., Ueda, T., Gejyo, F., & Naiki, H. (2002) · Biochimica et Biophysica Acta (BBA) - Proteins and Proteomics · doi:10.1016/s1570-9639(02)00435-1 · Cited by 26

The amyloid precursor protein gene: a neuropeptide gene with diverse functions in the central nervous system

Panegyres, P. K. (1997) · Neuropeptides · doi:10.1016/s0143-4179(97)90000-7 · Cited by 26

Polymorphism in the alpha1-antichymotrypsin (ACT) gene promoter: effect on expression in transfected glial and liver cell lines and plasma ACT concentrations

Morgan, K., Licastro, F., Tilley, L. A., Ritchie, A., Morgan, L., Pedrini, S., & Kalsheker, N. A. (2001) · Human Genetics · doi:10.1007/s004390100575 · Cited by 26

Investigation of the association between interleukin-1beta polymorphism and normal tension glaucoma.

Wang, C. Y., Shen, Y.-C., Su, C.-H., Lo, F.-Y., Lee, S.-H., Tsai, H.-Y., & Fan, S.-S. (2007) · PubMed Central · Cited by 25

Levels of cerebrospinal fluid apolipoprotein E in patients with Alzheimer's disease and healthy controls

Hahne, S., Nordstedt, C., Åhlin, A., & Nybäck, H. (1997) · Neuroscience Letters · doi:10.1016/s0304-3940(97)13477-2 · Cited by 25

Alpha-1 antichymotrypsin and alpha-2 macroglobulin gene polymorphisms are not associated with Korean late-onset Alzheimer's disease

Ki, C., Na, D. L., Kim, H. J., & Kim, J.-W. (2001) · Neuroscience Letters · doi:10.1016/s0304-3940(01)01660-3 · Cited by 25

Lysosomal deposition of Aβ in cultures of brain vascular smooth muscle cells is enhanced by iron

Frackowiak, J., Sukontasup, T., Potempska, A., & Mazur‐Kolecka, B. (2004) · Brain Research · doi:10.1016/j.brainres.2003.12.015 · Cited by 25

The Degradation of Amyloid β as a Therapeutic Strategy in Alzheimer's Disease and Cerebrovascular Amyloidoses

Morelli, L., Llovera, R. E., Ibendahl, S., & Castaño, E. M. (2002) · Neurochemical Research · doi:10.1023/a:1021679817756 · Cited by 25

The COOH-terminus of the Alzheimer amyloid Aβ peptide: Differences in length influence the process of amyloid deposition in Alzheimer brain, and tell us something about relationships among parenchymal and vessel-associated amyloid deposits

Greenberg, B. (1995) · Amyloid · doi:10.3109/13506129509036927 · Cited by 25

Cerebral amyloid angiopathy and apolipoprotein E: Bad news for the good allele?

Greenberg, S. M., & Hyman, B. T. (1997) · Annals of Neurology · doi:10.1002/ana.410410604 · Cited by 25

Use of Genetic Variation as Biomarkers for Alzheimer's Disease

Reitz, C., & Mayeux, R. (2009) · Annals of the New York Academy of Sciences · doi:10.1111/j.1749-6632.2009.04945.x · Cited by 24

Inflammation in Alzheimer’s disease

Heneka, M. T. (2006) · Clinical Neuroscience Research · doi:10.1016/j.cnr.2006.09.005 · Cited by 25

A reassessment of the telomere hypothesis of senescence

Reddel, R. R. (1999) · BioEssays · doi:10.1002/(sici)1521-1878(199812)20:12 · Cited by 65

Kinetic analysis of the polymerization and depolymerization of β2-microglobulin-related amyloid fibrils in vitro

Yamamoto, S., Hasegawa, K., Yamaguchi, I., Goto, Y., Gejyo, F., & Naiki, H. (2005) · Biochimica et Biophysica Acta (BBA) - Proteins and Proteomics · doi:10.1016/j.bbapap.2005.07.007 · Cited by 25

Sodium Dodecyl Sulfate-Resistant Complexes of Alzheimer’s Amyloid β-Peptide with the N-Terminal, Receptor Binding Domain of Apolipoprotein E

Golabek, A. A., Kida, E., Walus, M., Perez, C., Wısnıewskı, T., & Soto, C. A. (2000) · Biophysical Journal · doi:10.1016/s0006-3495(00)76354-5 · Cited by 24

Presenilins, β-amyloid precursor protein and the molecular basis of Alzheimer's disease

Selkoe, D. J. (2001) · Clinical Neuroscience Research · doi:10.1016/s1566-2772(00)00016-5 · Cited by 24

A Role for apoE in Regulating the Levels of α-1-Antichymotrypsin in the Aging Mouse Brain and in Alzheimer's Disease

Licastro, F., Campbell, I. L., Kincaid, C., Veinbergs, I., Uden, E. V., Rockenstein, E. M., Mallory, M. E., Gilbert, J. R., & Masliah, E. (1999) · American Journal Of Pathology · doi:10.1016/s0002-9440(10)65186-3 · Cited by 24

Plasma α1-antichymotrypsin in Alzheimer’s disease; relationships with APOE genotypes

Scacchi, R., Ruggeri, M., Gambina, G., Martini, M. C., Ferrari, G., & Corbo, R. M. (2001) · Neurobiology of Aging · doi:10.1016/s0197-4580(00)00246-3 · Cited by 24

Molecular biology of brain aging and neurodegenerative disorders

Wısnıewskı, T., & Frangione, B. (1996) · Acta Neurobiologiae Experimentalis · doi:10.55782/ane-1996-1132 · Cited by 24

Imipramine and olanzapine block apoE4-catalyzed polymerization of Aβ and show evidence of improving Alzheimer’s disease cognition

Johnson, N. R., Wang, A. C.-J., Coughlan, C. M., Sillau, S., Lucero, E., Viltz, L., Markham, N. E., Allen, C., Dhanasekaran, A. R., Chial, H. J., et al. (2022) · Alzheimer s Research & Therapy · doi:10.1186/s13195-022-01020-9 · Cited by 24

Effect of High Glucose Levels on Amyloid β Production in Retinas of Spontaneous Diabetes Mellitus Otsuka Long-Evans Tokushima Fatty Rats

Nagai, N., Ito, Y., & Tanino, T. (2015) · Biological and Pharmaceutical Bulletin · doi:10.1248/bpb.b14-00819 · Cited by 23

Deleterious network hypothesis of Alzheimer's disease

Ying, W. (1996) · Medical Hypotheses · doi:10.1016/s0306-9877(96)90021-3 · Cited by 21

Apolipoprotein E is Present in Primary Localized Cutaneous Amyloidosis

Furumoto, H., Shimizu, T., Asagami, C., Muto, M., Takahashi, M., Hoshii, Y., Ishihara, T., & Nakamura, K. (1998) · Journal of Investigative Dermatology · doi:10.1046/j.1523-1747.1998.00294.x · Cited by 23

Brain β-spectrin is a component of senile plaques in Alzheimer's disease

Sihag, R. K., & Cataldo, A. M. (1996) · Brain Research · doi:10.1016/s0006-8993(96)01058-x · Cited by 22

Physiopathological modulators of amyloid aggregation and novel pharmacological approaches in Alzheimer's disease

DEFELICE, F. G., & Ferreira, S. T. (2002) · Anais da Academia Brasileira de Ciências · doi:10.1590/s0001-37652002000200006 · Cited by 24

Genetics of cognition in epilepsy

Busch, R. M., Najm, I., Hermann, B. P., & Eng, C. (2014) · Epilepsy & Behavior · doi:10.1016/j.yebeh.2014.05.026 · Cited by 22

Serpins Inhibit the Toxicity of Amyloid Peptides

Schubert, D. A. (1997) · European Journal of Neuroscience · doi:10.1111/j.1460-9568.1997.tb01425.x · Cited by 21

Astrocytes in Neurodegenerative Diseases: A Perspective from Tauopathy and α-Synucleinopathy

Wang, P., & Ye, Y. (2021) · Life · doi:10.3390/life11090938 · Cited by 21

Hyperglycemia Enhances the Production of Amyloid β 1–42 in the Lenses of Otsuka Long-Evans Tokushima Fatty Rats, a Model of Human Type 2 Diabetes

Nagai, N., Ito, Y., & Sasaki, H. (2016) · Investigative Ophthalmology & Visual Science · doi:10.1167/iovs.15-19026 · Cited by 20

Segmented Linear Mixed Model Analysis Reveals Association of the APOE ɛ4 Allele with Faster Rate of Alzheimer’s Disease Dementia Progression

Chen, X. R., Initiative, A. D. N., Shao, Y., & Sadowski, M. J. (2021) · Journal of Alzheimer s Disease · doi:10.3233/jad-210434 · Cited by 22

Apolipoprotein E genotype, islet amyloid deposition and severity of Type 2 diabetes

Powell, D. S., Maksoud, H., CHARGÉ, S. B. P., Moffitt, J. H., Desai, M., Fihlo, R. L. D. S., Hattersley, A. T., STRATTON, I. M., Matthews, D. R., Lévy, J., et al. (2003) · Diabetes Research and Clinical Practice · doi:10.1016/s0168-8227(02)00281-4 · Cited by 20

A positive feedback loop between nitric oxide and amyloid β (1-42) accelerates mitochondrial damage in human lens epithelial cells

Nagai, N., Ito, Y., Shibata, T., Kubo, E., & Sasaki, H. (2017) · Toxicology · doi:10.1016/j.tox.2017.02.014 · Cited by 20

Alpha 1-antichymotrypsin interaction with A beta (1-42) does not inhibit fibril formation but attenuates the peptide toxicity.

Aksenov, M. Y., Aksenova, M. V., Jm, C., & Butterfield, D. A. (1996) · PubMed · Cited by 21

Biological Markers for the Clinical Diagnosis of Alzheimer's Disease.

Arai, H. (1996) · The Tohoku Journal of Experimental Medicine · doi:10.1620/tjem.179.65 · Cited by 21

Concerted Regulation of Inhibitory Activity of α1-Antitrypsin by the Native Strain Distributed throughout the Molecule

Seo, E. J., Lee, C., & Yu, M. (2002) · Journal of Biological Chemistry · doi:10.1074/jbc.m110272200 · Cited by 21

Molecular pathogenesis of apolipoprotein E-mediated amyloidosis in late-onset Alzheimer's disease

Tomiyama, T., Corder, E. H., & Mori, H. (1999) · Cellular and Molecular Life Sciences · doi:10.1007/s000180050428 · Cited by 22

Inflammatory Mediators in Alzheimer’s Disease

Rogers, J., & O’Barr, S. A. (1997) · Humana Press eBooks · doi:10.1007/978-1-59259-471-9_11 · Cited by 19

Is There a Genetic Basis for the Deposition of β-Amyloid After Fatal Head Injury?

Graham, D. I., Gentleman, S. M., Nicoll, J. A. R., Royston, M. C., McKenzie, J. E., Roberts, G. W., Mrak, R. E., & Griffin, W. S. T. (1999) · Cellular and Molecular Neurobiology · doi:10.1023/a:1006956306099 · Cited by 21

Excessive hydrogen peroxide enhances the attachment of amyloid β1–42 in the lens epithelium of UPL rats, a hereditary model for cataracts

Nagai, N., & Ito, Y. (2013) · Toxicology · doi:10.1016/j.tox.2013.08.003 · Cited by 20

Immunohistochemical characterization of novel monoclonal antibodies against the N-terminus of amyloid β-peptide

Verwey, N. A., Hoozemans, J. J. M., Korth, C., van Royen, M. R., Prikulis, I., Wouters, D., Twaalfhoven, H. A. M., van Haastert, E. S., Schenk, D., Scheltens, P., et al. (2013) · Amyloid · doi:10.3109/13506129.2013.797389 · Cited by 21

Future horizons in Alzheimer's disease research

Wısnıewskı, T., & Drummond, E. (2019) · Progress in molecular biology and translational science · doi:10.1016/bs.pmbts.2019.08.001 · Cited by 20

Mathematical Model Shows How Sleep May Affect Amyloid-β Fibrillization

Hoore, M., Khailaie, S., Montaseri, G., Mitra, T., & Meyer‐Hermann, M. (2020) · Biophysical Journal · doi:10.1016/j.bpj.2020.07.011 · Cited by 22

Recovery of deficient cholinergic calcium signaling by adenosine in cultured rat cortical astrocytes

Ferroni, S., Marchini, C., Ogata, T., & Schubert, P. (2002) · Journal of Neuroscience Research · doi:10.1002/jnr.10248 · Cited by 20

Hydrogen sulfide induced supramolecular self-assembly in living cells

Wei, S., Zhou, X., Huang, Z., Yao, Q., & Gao, Y. (2018) · Chemical Communications · doi:10.1039/c8cc05174g · Cited by 20

The molecular significance of amyloid β-peptide for Alzheimer's disease

Haass, C. (1996) · European Archives of Psychiatry and Clinical Neuroscience · doi:10.1007/bf02189111 · Cited by 20

Molecular chaperones and disease

Henderson, B. E., Nair, S. P., & Coates, A. R. M. (1996) · Inflammation Research · doi:10.1007/bf02285154 · Cited by 20

Platelet secretion of β-amyloid is increased in hypercholesterolaemia

Smith, C., Hyatt, P. J., Stanyer, L., & Betteridge, D. J. (2001) · Brain Research · doi:10.1016/s0006-8993(01)02080-7 · Cited by 20

D2 dopamine receptor polymorphism and brain regional glucose metabolism

Noble, E. P., Gottschalk, L. A., Fallon, J. H., Ritchie, T. L., & Wu, J. C. (1997) · American Journal of Medical Genetics · doi:10.1002/(sici)1096-8628(19970418)74:2 · Cited by 165

Perspectives in clinical Alzheimer’s disease research and the development of antidementia drugs

Grundman, M., Corey‐Bloom, J., & Thal, L. J. (1998) · Journal of neural transmission. Supplementum · doi:10.1007/978-3-7091-6467-9_23 · Cited by 20

Associative Interactions among Zinc, Apolipoprotein E, and Amyloid-β in the Amyloid Pathology

Oh, S. B., Kim, J. A., Park, S., & Lee, J. (2020) · International Journal of Molecular Sciences · doi:10.3390/ijms21030802 · Cited by 19

Evidence that Alzheimer’s Disease Is a Disease of Competitive Synaptic Plasticity Gone Awry

Huang, Z. (2024) · Journal of Alzheimer s Disease · doi:10.3233/jad-240042 · Cited by 20

Transcriptional regulation of APP by apoE: To boldly go where no isoform has gone before

Lee, L. C., Goh, M. Q. L., & Koo, E. H. (2017) · BioEssays · doi:10.1002/bies.201700062 · Cited by 20

SILAC ‐based proteomic analysis to investigate the impact of amyloid precursor protein expression in neuronal‐like B 103 cells

Chaput, D., Kirouac, L., Bell‐Temin, H., Stevens, S. M., & Padmanabhan, J. (2012) · Electrophoresis · doi:10.1002/elps.201200251 · Cited by 20

Combination of plasma biomarkers and clinical data for the detection of sporadic Alzheimer's disease

Han, Y., Jia, J., Jia, X., Qin, W., & Wang, S. (2012) · Neuroscience Letters · doi:10.1016/j.neulet.2012.03.094 · Cited by 19

Laminin inhibits Aβ40 fibril formation promoted by apolipoprotein E4 in vitro

Monji, A., Tashiro, K., Yoshida, I., Hayashi, Y., & Tashiro, N. (1998) · Brain Research · doi:10.1016/s0006-8993(98)00342-4 · Cited by 19

The Distribution of β-Amyloid Precursor Protein in Rat Cortex after Systemic Kainate-Induced Seizures

Shoham, S., & Ebstein, R. P. (1997) · Experimental Neurology · doi:10.1006/exnr.1997.6622 · Cited by 19

Cholesterol and Alzheimer’s Disease: Statins, Cholesterol Depletion in APP Processing and Aβ Generation

Hartman, T. (2006) · Springer eBooks · doi:10.1007/0-387-23226-5_19 · Cited by 20

Erbliche Ursachen und Risikofaktoren der Alzheimer-Krankheit

Lautenschlager, N. T., Kurz, A., & Müller, U. (1999) · Der Nervenarzt · doi:10.1007/s001150050423 · Cited by 19

MOLECULAR GENETICS OF ALZHEIMER'S DISEASE With special emphasis on presenilin, amyloid beta precursor protein and apolipoprotein E genes

Yliopisto, K., & Helisalmi, S. (1998) · Cited by 19

Study of Exosomes Shed New Light on Physiology of Amyloidogenesis

van Niel, G. (2016) · Cellular and Molecular Neurobiology · doi:10.1007/s10571-016-0357-0 · Cited by 20

Alzheimer Aβ neurotoxicity: Promotion by antichymotrypsin, ApoE4; inhibition by Aβ-related peptides

Ma, J., Brewer, H. B., & Potter, H. (1996) · Neurobiology of Aging · doi:10.1016/0197-4580(96)00112-1 · Cited by 108

Fibrillogenesis in Alzheimer's disease of amyloid β peptides and apolipoprotein E

Castano, E. M., Prelli, F., Wisniewski, T., Golabek, A., Kumar, R. A., Soto, C., & Frangione, B. (1995) · Biochemical Journal · doi:10.1042/bj3060599 · Cited by 267

Apolipoprotein is required for the formation of filamentous amyloid, but not for amorphous Aβ deposition, in an AβPP/PS double transgenic mouse model of Alzheimer's disease

Costa, D. A., Nilsson, L. N. G., Bales, K. R., Paul, S. M., & Potter, H. (2004) · Journal of Alzheimer s Disease · doi:10.3233/jad-2004-6508 · Cited by 14

Acceleration of Alzheimer's fibril formation by apolipoprotein E in vitro.

(1994) · PubMed Central · Cited by 441

Apolipoprotein E is a kinetic but not a thermodynamic inhibitor of amyloid formation: implications for the pathogenesis and treatment of Alzheimer disease

Evans, K. C., Berger, E. P., Cho, C. G., Weisgraber, K. H., & Lansbury, P. T. (1995) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.92.3.763 · Cited by 333